Markus Anliker

Title: Innovations of Markus Anliker

Introduction

Markus Anliker is a notable inventor based in Amstetten, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of complement inhibitors. His work focuses on innovative solutions for medical applications, specifically in treating diseases related to inappropriate complement activation.

Latest Patents

Markus Anliker holds a patent titled "Complement inhibitors and uses thereof." This invention involves a multi-domain polypeptide that includes a complement control protein repeat domain, a host cell recognition domain, and additional domains with cofactor activity. The invention also encompasses a polynucleotide encoding the polypeptide, a vector containing the polynucleotide, and a host cell that incorporates the polynucleotide and/or vector. The applications of this invention are aimed at preventing and treating diseases associated with inappropriate complement activation.

Career Highlights

Throughout his career, Markus Anliker has worked at prestigious institutions, including the University of Ulm. His research has contributed to advancements in medical science, particularly in understanding and manipulating the complement system for therapeutic purposes.

Collaborations

Markus Anliker has collaborated with esteemed colleagues such as Christoph Schmidt and Hubert Schrezenmeier. These partnerships have enhanced the scope and impact of his research in the field of biotechnology.

Conclusion

Markus Anliker is a prominent inventor whose work on complement inhibitors has the potential to revolutionize treatments for diseases linked to complement system dysfunction. His contributions to biotechnology continue to pave the way for innovative medical solutions.